India to Australia: Naproxen Export Trade Route
India has recorded 33 verified shipments of Naproxen exported to Australia, representing a combined trade value of $1.1M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $33.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 96% of total export value with 28 shipments worth $1.1M USD. On the buying side, ARROW PHARMACEUTICALS PTY LTD is the largest importer in Australia with $506.1K USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , SAI PARENTERAL S LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Naproxen corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $1.1M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's naproxen manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $33.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with naproxen's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 30.2%, placing it at rank #9 among India's top naproxen export destinations globally.
On the import side, key buyers of Indian naproxen in Australia include ARROW PHARMACEUTICALS PTY LTD, APOTEX AUSTRALIA, NOUMED PHARMACEUTICALS PTY LTD and 8 others. ARROW PHARMACEUTICALS PTY LTD is the single largest importer with 9 shipments valued at $506.1K USD.
Route Characteristics
- Average transit
